Ethylestrenol
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-
2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro- 1H-cyclopenta[a]phenanthren-17-ol |
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Identifiers | |
CAS Number | 965-90-2 ![]() |
ATC code | A14AB02 (WHO) |
PubChem | CID: 13765 |
IUPHAR/BPS | 6948 |
DrugBank | DB01493 ![]() |
ChemSpider | 13168 ![]() |
UNII | ADC79EK5Q8 ![]() |
KEGG | D01414 ![]() |
ChEBI | CHEBI:31578 ![]() |
ChEMBL | CHEMBL1200623 ![]() |
Chemical data | |
Formula | C20H32O |
Molecular mass | 288.467 g/mol |
|
|
|
|
![]() ![]() |
Ethylestrenol (brand names Maxibolin, Orabolin), also known as 17α-ethylestr-4-en-17β-ol, is an anabolic steroid with some progestogenic activity, and little androgenic activity. It is a nandrolone derivative and lacks the 3-keto functional group. It was approved in 1964 for testosterone deficiency in male patients.[1]
See also
- Nandrolone (17β-hydroxyestra-4-en-3-one)
- Ethisterone (17α-ethynyl-17β-hydroxyandrost-4-en-3-one)
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>